PRPH
USDProPhase Labs Inc. Common Stock (DE)
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.288
High
$0.288
Low
$0.257
Volume
0.76M
Company Fundamentals
Market Cap
11.7M
Industry
Diagnostics & Research
Country
United States
Trading Stats
Avg Volume
6.45M
Exchange
NCM
Currency
USD
52-Week Range
AI Analysis Report
Last updated: Nov 10, 2025PRPH (ProPhase Labs Inc.) Market Analysis: Unlocking Value Despite Mixed Signals
News Sentiment Overview
Recent headlines highlight major validation for ProPhase Labs
Related News
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives
ProPhase Labs to Present at the 2025 ThinkEquity Conference
UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics, and consumer products company, today announced that it will be
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH) ("ProPhase" or the
AI PredictionBeta
AI Recommendation
Updated at: Nov 10, 2025, 09:37 AM
58.2% Confidence
Risk & Trading
Entry Point
$0.27
Take Profit
$0.33
Stop Loss
$0.25
Key Factors
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.